Schizophrenia and Related Disorders Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Schizophrenia and Related Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Social Isolation and Aging in Schizophrenia

Schizophrenia and Related Disorders
Icahn School of Medicine at Mount Sinai650 enrolled4 locationsNCT07419321
Recruiting
Not Applicable

Clay Therapy in Schizophrenia Patients

Schizophrenia and Related Disorders
Kutahya Health Sciences University17 enrolled1 locationNCT07378150
Recruiting
Not Applicable

rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Schizophrenia and Related Disorders
National Taiwan University Hospital180 enrolled1 locationNCT05671185
Recruiting
Phase 3

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Major Depressive DisorderBipolar DepressionSchizophrenia and Related Disorders
Dr. Inge Winter1,254 enrolled1 locationNCT05603104
Recruiting
Not Applicable

Exercise Therapy in Mental Disorders-study

Bipolar DisorderSchizophrenia and Related Disorders
Haukeland University Hospital50 enrolled1 locationNCT06313918
Recruiting
Not Applicable

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

Schizophrenia and Related Disorders
The University of Texas Health Science Center, Houston120 enrolled1 locationNCT07060066
Recruiting
Not Applicable

Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS

PsychosisDepressive EpisodeSchizophrenia and Related Disorders+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)24 enrolled1 locationNCT06426134
Recruiting
Not Applicable

SPARK Healthy Sleep

Sleep DisturbanceSchizophrenia and Related Disorders
Indiana University115 enrolled1 locationNCT07119268
Recruiting
Phase 4

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Schizophrenia and Related DisordersEarly Treatment-Resistance
Dr. Inge Winter418 enrolled13 locationsNCT05958875
Recruiting
Phase 2Phase 3

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Cognitive ImpairmentMitochondrial AlterationSchizophrenia and Related Disorders
Mclean Hospital100 enrolled3 locationsNCT06191965
Recruiting
Not Applicable

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

Schizophrenia and Related Disorders
The University of Texas Health Science Center, Houston140 enrolled1 locationNCT02916810
Recruiting

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

Anxiety DepressionSchizophrenia and Related Disorders
The University of Hong Kong10 enrolled1 locationNCT05169268
Recruiting
Phase 4

"Extended" (Alternate Day) Antipsychotic Dosing

Drug TherapySchizophrenia and Related DisordersAntipsychotic Agents+1 more
Centre for Addiction and Mental Health120 enrolled1 locationNCT04478838
Recruiting
Not Applicable

Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices

Psychotic DisordersSchizophrenia and Related DisordersAuditory Hallucination
Swinburne University of Technology212 enrolled1 locationNCT05982158
Recruiting

Semantic and Syntactic Computerized Analysis of Free Speech

Psychotic DisordersPsychosisSchizophrenia and Related Disorders+2 more
University Hospital, Brest150 enrolled3 locationsNCT03525054